Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
US |
|
Atlantic Sapphire ASA
OSE:ASA
|
NO |
|
A
|
Ascopiave SpA
DUS:AVA
|
IT |
Intrinsic Value
The
intrinsic value for
Phathom Pharmaceuticals Inc (PHAT)
under the Base Case is
34.8
USD.
Compared with the current market price of 12.64 USD, the stock appears
Undervalued by 64%.
Both DCF and multiples point to undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Phathom Pharmaceuticals Inc.
The
intrinsic value for
Phathom Pharmaceuticals Inc (PHAT)
under the Base Case is
34.8
USD.
Compared with the current market price of 12.64 USD, the stock appears Undervalued by 64%.